Investor Resources Home

Webcast ImageWebcast - Replay
Heron Therapeutics Inc at Oppenheimer & Co. Inc. 27th Annual Healthcare Conference
03/21/17 at 10:55 a.m. ET
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$14.75
Change (%) Stock is Up 0.35 (2.43%)
Volume405,370
Data as of 03/24/17 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
03/21/17
Download Documentation Company Update (March)

Recent News

More >>
DateTitle 
03/13/17Heron Therapeutics to Present at the Oppenheimer 27th Annual Healthcare ConferencePrinter Friendly Version
02/28/17Heron Therapeutics to Present at the 37th Annual Cowen and Company Healthcare ConferencePrinter Friendly Version
02/24/17Heron Therapeutics Announces Inclusion of SUSTOL® (Granisetron) Extended-Release Injection in NCCN® Antiemesis GuidelinesPrinter Friendly Version
02/23/17Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate ProgressPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.